EDAN(SZ:300206) Ge Long Hui A P P·2026-01-19 12:29Core Viewpoint - The company, Lifesense Instruments (300206.SZ), expects a significant increase in net profit for 2025, projecting a growth of 75.00% to 105.00% compared to the previous year, driven by its strategic focus on innovation, platform development, and internationalization [1] Group 1: Financial Projections - The estimated net profit attributable to shareholders for 2025 is between 283.69 million and 332.32 million yuan, with a year-on-year growth of 75.00% to 105.00% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 272.94 million and 316.04 million yuan, reflecting a growth of 90.00% to 120.00% year-on-year [1] Group 2: Strategic Initiatives - The company continues to implement its development strategy focused on "innovation, platform-based, and internationalization," enhancing its global business layout and service capabilities in overseas markets [1] - The company is advancing its overseas manufacturing strategy and optimizing its marketing system, with a notable double-digit growth in international markets, particularly in patient monitoring and ultrasound imaging businesses [1] Group 3: Operational Efficiency - The company has focused on improving operational management and has effectively reduced marketing and R&D expenses while aiming for quality enhancement and efficiency [1] - The impact of non-recurring gains and losses on net profit is expected to be around 14 million yuan, primarily from government subsidies, which is a decrease of approximately 4 million yuan compared to the previous year [1]